General awareness of the rising global prevalence of kidney disease has been steadily growing among medical and public health professionals. Kidney disease is the eighth leading cause of death in the U.S. with approximately 600,000 patients in end-stage renal disease (ESRD, most receiving dialysis) and over 26 million in earlier stages of chronic kidney disease (CKD).
As the population continues to age and the epidemiological shift from acute infectious to chronic metabolic diseases progresses, contributing factors to kidney disease (obesity, diabetes, and hypertension) become epidemic. Kidney disease may turn into a major health crisis in the USA and globally. Existing worldwide statistical data on the incidence and prevalence of kidney disease and kidney failure, the resulting mortality, the high cost of treatment, and associated socioeconomic and political consequences present a compelling and urgent need for an effective, easy to use and affordable alternative adjunct treatment modality to be available to the global kidney patient population.
Please find the complete article at https://www.omicsonline.org/open-access/concept-and-potential-of-enteric-dialysis--treating-the-cause-of-dysbiosis-and-not-the-symptoms-in-chronic-kidney-diseases-ckd-2161-0959-1000209.php?aid=58066